Hypertrophic cardiomyopathy (HCM) is a relatively common genetic heart disease
encumbered throughout much of its almost 60-year history by a large measure of …

Background The influence of left ventricular outflow tract obstruction on the clinical outcome
of hypertrophic cardiomyopathy remains unresolved. Methods We assessed the effect of …

Background Hypertrophic cardiomyopathy is a genetic disease associated with a risk of
ventricular tachyarrhythmias and sudden death, especially in young patients. Methods We …

Background—Death resulting from hypertrophic cardiomyopathy (HCM), particularly when
sudden, has been reported to be largely confined to young persons. These data emanated …

Background Clinical impact of atrial fibrillation (AF) in hypertrophic cardiomyopathy (HCM) is
largely unresolved. Thus, we analyzed the prognostic implications of AF in a large …

ContextHypertrophic cardiomyopathy (HCM) has been regarded as a disease that causes
substantial disability, with annual mortality rates of up to 6%, based largely on reports from …

Background—Two-dimensional echocardiography is currently the standard test for the
clinical diagnosis of hypertrophic cardiomyopathy (HCM). The present study was undertaken …

Objectives: The goal of this study was to assess gender-related differences in a multicenter
population with hypertrophic cardiomyopathy (HCM). Background: Little is known regarding …

Background—Unexplained left ventricular hypertrophy (LVH) is considered diagnostic of
hypertrophic cardiomyopathy (HCM) but fails to identify all genetically affected individuals …

Objectives: We sought to assess the occurrence and clinical significance of stroke and
peripheral arterial embolizations at non-central nervous system sites in a large, community …